Kappa Bioscience appoints Rena Cohen-First as vice president of sale for North America
Rena Cohen-First will be based out of the company’s New Jersey office.
Photo © iStockphoto.com/skynesher
Kappa Bioscience (Oslo, Norway) appointed Rena Cohen-First as vice president of sales North America. Previously, Cohen-First was vice president of sales at OmniActive Health for the company’s western region. She will be based out of the company’s New Jersey office.
"Kappa is a remarkable leader, truly pushing the tipping point of K2's global impact on health and wellness,” said Cohen-First in a press release. “I'm excited to work with our partners to help bring this awareness to North American consumers."
FDA revokes authorization to use Red No. 3 as a color additive in food or drugs
January 15th 2025FDA contends that the color additive is safe for humans but is legally obligated by the Delaney Clause of the FD&C act to revoke authorization as research shows the Red No. 3 induces cancer in rats.
